AXGN – AxoGen, Inc.

AXGN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

6.59

Margin Of Safety %

-30

Put/Call OI Ratio

0.34

EPS Next Q Diff

0.19

EPS Last/This Y

0.83

EPS This/Next Y

0.24

Price

40.92

Target Price

50.7

Analyst Recom

1.1

Performance Q

15.6

Upside

-153.9%

Beta

1.16

Ticker: AXGN

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-24	AXGN	39.26	0.24	0.27	579
2026-04-27	AXGN	39.35	0.25	0.11	611
2026-04-28	AXGN	42.26	0.24	0.42	636
2026-04-29	AXGN	41.78	0.30	1.15	698
2026-04-30	AXGN	43.23	0.33	0.00	715
2026-05-01	AXGN	43.28	0.33	1.00	716
2026-05-04	AXGN	42.68	0.33	0.00	719
2026-05-05	AXGN	43.73	0.33	0.00	725
2026-05-06	AXGN	43.46	0.32	1.00	730
2026-05-07	AXGN	43.43	0.32	0.00	731
2026-05-08	AXGN	42.07	0.32	999.99	734
2026-05-11	AXGN	40.63	0.32	0.81	733
2026-05-12	AXGN	40.95	0.33	0.27	734
2026-05-13	AXGN	40.34	0.31	0.22	727
2026-05-14	AXGN	40.94	0.30	0.00	729
2026-05-15	AXGN	41.03	0.29	0.06	723
2026-05-18	AXGN	42.01	0.30	0.47	552
2026-05-19	AXGN	42.72	0.31	7.67	570
2026-05-20	AXGN	42.66	0.36	0.04	595
2026-05-21	AXGN	41.34	0.34	0.00	622
2026-05-22	AXGN	40.89	0.34	0.67	623
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-24	AXGN	39.29	457.2	-	0.53
2026-04-27	AXGN	39.35	457.2	-	0.53
2026-04-28	AXGN	41.95	457.2	-	0.53
2026-04-30	AXGN	43.22	457.2	-	0.53
2026-05-01	AXGN	43.29	11.1	-	0.53
2026-05-04	AXGN	42.64	11.1	-	0.53
2026-05-05	AXGN	43.77	-1.2	-	0.49
2026-05-06	AXGN	43.47	-1.2	-	0.49
2026-05-07	AXGN	43.43	-1.2	-	0.49
2026-05-08	AXGN	42.07	-1.2	-	0.49
2026-05-11	AXGN	40.78	-1.2	-	0.49
2026-05-12	AXGN	40.96	-1.2	-	0.49
2026-05-13	AXGN	40.29	-1.2	-	0.49
2026-05-14	AXGN	40.95	-1.2	-	0.49
2026-05-15	AXGN	41.00	-1.2	-	0.49
2026-05-18	AXGN	41.96	-1.2	-	0.49
2026-05-19	AXGN	42.69	-1.2	-	0.49
2026-05-20	AXGN	42.69	-1.2	-	0.49
2026-05-21	AXGN	41.33	-1.2	-	0.49
2026-05-22	AXGN	40.92	-1.2	-	0.49
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-24	AXGN	-29.75	4.69	6.88
2026-04-27	AXGN	-29.69	8.04	7.34
2026-04-28	AXGN	-29.69	8.04	7.34
2026-04-29	AXGN	-29.69	8.04	7.34
2026-04-30	AXGN	-29.69	8.04	7.34
2026-05-01	AXGN	-26.40	8.04	0
2026-05-04	AXGN	-26.40	7.88	7.16
2026-05-05	AXGN	-26.40	7.88	7.16
2026-05-06	AXGN	-26.40	7.88	7.16
2026-05-07	AXGN	-26.40	7.88	7.16
2026-05-08	AXGN	-25.56	7.88	7.16
2026-05-11	AXGN	-27.35	7.36	7.18
2026-05-12	AXGN	-24.73	7.36	6.55
2026-05-13	AXGN	-24.81	7.36	6.55
2026-05-14	AXGN	-23.77	7.36	6.55
2026-05-15	AXGN	-23.77	7.36	6.55
2026-05-18	AXGN	-23.77	2.52	6.57
2026-05-19	AXGN	-22.53	2.52	6.57
2026-05-20	AXGN	-22.53	2.52	6.57
2026-05-21	AXGN	-22.53	2.52	6.59
2026-05-22	AXGN	-20.02	2.52	6.59
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.05

Avg. EPS Est. Current Quarter

0.12

Avg. EPS Est. Next Quarter

0.14

Insider Transactions

-20.02

Institutional Transactions

2.52

Beta

1.16

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

28.84

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

10.7

Max Drawdown 5-Year %

-83.7

Target Price

50.7

P/E

Forward P/E

56.9

PEG

1.15

P/S

9.13

P/B

8.88

P/Free Cash Flow

234.37

EPS

-0.63

Average EPS Est. Cur. Y

0.49

EPS Next Y. (Est.)

0.73

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-13.21

Relative Volume

0.46

Return on Equity vs Sector %

-39.9

Return on Equity vs Industry %

-24.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

◆ AXGN Healthcare

$40.90

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

2/20

Pullback

17/25

Volume

11/15

Valuation

11/20

TP/AR

4/10

Options

8/10

RSI

53.5

Range 1M

46.5%

Sup Dist

1.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

21/30

Estimates

4/20

Inst/Vol

7/15

Options

7/10

EPS Yr

71.1%

EPS NY

44.8%

52W%

86.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -22.8% upside

Quality

6/30

Valuation

3/30

Growth

15/25

Stability

8/10

LT Trend

1/5

Upside

-22.8%

Quality

MoS

-30%

AxoGen, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 622

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.

AXGN

Latest News

—

Caricamento notizie per AXGN…

stock quote shares AXGN – AxoGen, Inc. Stock Price stock today

news today AXGN – AxoGen, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch AXGN – AxoGen, Inc. yahoo finance google finance

stock history AXGN – AxoGen, Inc. invest stock market

stock prices AXGN premarket after hours

ticker AXGN fair value insiders trading

AXGN – AxoGen, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: AXGN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y